Zoledronic Acid in MS-patients With Osteoporosis

Clinical trial NCT01166178 · TERMINATED

Trial details

NCT number: NCT01166178
Sponsor: Novartis
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Osteoporosis Multiple Sclerosis

Start date: 2010-10-01
Primary completion: 2012-06-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.